compound introduction
Sipoglitazar 是一种新型的抗糖尿病药，因为它对三种人类过氧化物酶体增殖物激活的受体hPPAR-γ，-α和-δ具有激动作用 Sipoglitazar is a novel antidiabetic agent due to its agonistic activities on the three human peroxisome proliferator-activated receptors, hPPAR-γ, -α, and -δ
All
Chemical Reagents
Biomedicine
Organic raw materials
Inorganic chemical industry
intermediate
Agricultural chemicals
Auxiliaries and catalysts
Fragrances and Flavors
Dyes and Pigments
Daily chemical industry
Sipoglitazar
CAS number：342026-92-0 molecular formula：C25H25N3O4S
overview
Specs
| Chinese alias | 西格列净 | ||
| English alias | BCP33099 | TAK-654; TAK 654; TAK654 | 3-(3-ethoxy-1-((4-((2-phenyl-1,3-thiazol-4-yl)methoxy)phenyl)methyl)pyrazol-4-yl)propanoic acid | 3-[3-ethoxy-1-[4-(2-phenyl-4-thiazolylmethoxy)benzyl]-1H-pyrazol-4-yl]propionic acid | DTXSID50870331 | Sipoglitazar | | ||
| CAS number | 342026-92-0 | molecular formula | C25H25N3O4S |
| molecular weight | 463.55 g/mol | Exact mass | - |
| PSA | 115.000 Ų | logp | 4.500 |
numbering system
No numbering system information yet
physicochemical properties
No physical and chemical property information yet
Safety information
No safety information yet
Production methods and uses
No production method and use information yet
Related
upstream information
No upstream information yet
downstream information
No downstream information yet
MSDS
Found 0 shareMSDS
